Please use this identifier to cite or link to this item: https://repository.southwesthealthcare.com.au/swhealthcarejspui/handle/1/3825
Journal Title: Characteristics and outcomes of Aboriginal and Torres Strait Islander patients with dialysis-dependent kidney disease in Australian intensive care units
Authors: Dunlop, William A.
Secombe, Paul J.
Agostino, Jason W.
van Haren, Frank M.P.
Keywords: Indigenous Health
Chronic Kidney Disease
Dialysis Dependence
Intensive Care
Issue Date: 4-Oct-2020
Publisher: Wiley
Date Accessioned: 2023-04-17T03:12:01Z
Date Available: 2023-04-17T03:12:01Z
Url: https://doi.org/10.1111/imj.15077
Source Volume: 52
Issue Number: 3
DOI: https://doi.org/10.1111/imj.15077
Date: 2022-03
Abstract: Background In Australia, 531 people per million population have dialysis-dependent chronic kidney disease (CKD5D). The incidence is four times higher for Aboriginal and Torres Strait Islander (indigenous) people compared with non-Indigenous Australians. CKD5D increases the risk of hospitalisation, admission to the intensive care unit (ICU) and mortality compared with patients without CKD5D. There is limited literature describing short-term outcomes of patients with CKD5D who are admitted to the ICU, comparing indigenous and non-indigenous patients. Aims This registry-based retrospective cohort analysis compared demographic and clinical data between indigenous and non-indigenous patients with CKD5D and tested whether indigenous status predicted short-term outcomes independently of other contributing factors. Adjusted hospital mortality was the primary outcome measure. Methods Data were from the Australian and New Zealand Intensive Care Society's Centre for Outcome and Resource Evaluation Adult Patient Database. Australian ICU admissions between 2010 and 2017 were included. Data from 173 ICU (2136 beds) include 1 051 697 ICU admissions, of which 23 793 had a pre-existing diagnosis of CKD5D. Results Indigenous patients comprised 11.9% of CKD5D patients in ICU. CKD5D was prevalent among 4.9% of indigenous and 2.9% of non-indigenous ICU admissions. Indigenous patients were 13.5 years younger, had fewer comorbidities and lower crude mortality despite equivalent calculated mortality risk. After adjusting for age, remoteness and severity of illness, indigenous status did not predict mortality. Conclusions Socioeconomic disadvantage contributes to earlier development of CKD5D and the overrepresentation in ICU of indigenous people. Mortality is equivalent once correcting for confounders, but addressing inequality requires strengthening preventative care.
URI: https://repository.southwesthealthcare.com.au/swhealthcarejspui/handle/1/3825
Journal Title: Internal Medicine Journal
ISSN: 1445-5994
Type: Journal Article
Appears in Collections:SWH Data Contributions

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Google Media

Google ScholarTM

Who's citing